Jan 09, 2017 13:00 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Jan. 09, 2017 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that theUS Food and Drug Administration(FDA) has accepted...
Denny’s Corporation Releases Preliminary Financial Results for Fourth Quarter and Fiscal Year 2016
Jan 09, 2017 13:00 pm UTC| Business
SPARTANBURG, S.C., Jan. 09, 2017 -- Denny’s Corporation (NASDAQ:DENN), franchisor and operator of one of America's largest franchised full-service restaurant chains, today reported preliminary results for domestic...
Inovalon Extends Partnership With Anthem
Jan 09, 2017 12:55 pm UTC| Business
BOWIE, Md., Jan. 09, 2017 -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the...
Evercel Announces Annual Meeting of Stockholders
Jan 09, 2017 12:47 pm UTC| Business
NEW YORK, Jan. 09, 2017 -- Evercel, Inc. (OTC:EVRC) today announced that it will hold its 2017 annual meeting of stockholders on Thursday, January 26, 2017 at 10:00 a.m. Eastern Time. The annual meeting will be held at...
Jan 09, 2017 12:45 pm UTC| Business
Ft. Lauderdale, Jan. 09, 2017 -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company, which focuses on cannabis (industrial hemp), cannabinoid research and development,...
Novelion Therapeutics Reports Preliminary 2016 Net Product Sales and Provides 2017 Outlook
Jan 09, 2017 12:41 pm UTC| Business
- Company Reports Preliminary Total Net Product Sales Expected to be Between$150 million and $152 million, Exceeding High End of Prior Guidance - Global Expansion Plans for Metreleptin Opportunity Underway VANCOUVER,...
Jan 09, 2017 12:31 pm UTC| Business
NEW YORK, Jan. 09, 2017 -- TG Therapeutics, Inc.(NASDAQ:TGTX) today announced that theU.S. Food and Drug Administration(FDA) has granted orphan drug designation covering the combination of TG-1101 (ublituximab), the...